Bryan Irving Insider Trading $FPRX FIVE PRIME THERAPEUTICS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Bryan Irving.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Bryan Irving. Bryan Irving is EVP, Chief Scientific Officer in FIVE PRIME THERAPEUTICS INC ($FPRX) and SVP, Research in FIVE PRIME THERAPEUTICS INC ($FPRX).
Bryan Irving in FIVE PRIME THERAPEUTICS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Bryan Irving: EVP, Chief Scientific Officer, SVP, Research
Holdings: 30,533 shares
Current Value: $1,385,588
Latest Transaction: May 16 2019
$FPRX Market Capitalization: $1.23B
$FPRX Previous Close: $45.38
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Bryan Irving in FIVE PRIME THERAPEUTICS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 16 2019 | FPRX | FIVE PRIME THERAPE ... | Irving Bryan | EVP, Chief Scientif ... | Payment of Exercise | F | 9.17 | 620 | 5,685 | 30,533 | 31.2 K to 30.5 K (-1.99 %) |
| Feb 27 2019 | FPRX | FIVE PRIME THERAPE ... | Irving Bryan | EVP, Chief Scientif ... | Option Exercise | A | 11.97 | 58,000 | 694,260 | 58,000 | |
| Feb 27 2019 | FPRX | FIVE PRIME THERAPE ... | Irving Bryan | EVP, Chief Scientif ... | Payment of Exercise | F | 11.95 | 1,118 | 13,360 | 31,153 | 32.3 K to 31.2 K (-3.46 %) |
| Feb 27 2019 | FPRX | FIVE PRIME THERAPE ... | Irving Bryan | EVP, Chief Scientif ... | Grant | A | 0.00 | 10,000 | 0 | 32,271 | 22.3 K to 32.3 K (+44.90 %) |
| Sep 05 2018 | FPRX | FIVE PRIME THERAPE ... | Irving Bryan | EVP, Chief Scientif ... | Payment of Exercise | F | 14.00 | 2,479 | 34,706 | 22,271 | 24.8 K to 22.3 K (-10.02 %) |
| May 14 2018 | FPRX | FIVE PRIME THERAPE ... | Irving Bryan | EVP, Chief Scientif ... | Option Exercise | A | 17.27 | 22,500 | 388,575 | 22,500 | |
| May 14 2018 | FPRX | FIVE PRIME THERAPE ... | Irving Bryan | EVP, Chief Scientif ... | Grant | A | 0.00 | 3,750 | 0 | 24,750 | 21 K to 24.8 K (+17.86 %) |
| Feb 28 2018 | FPRX | FIVE PRIME THERAPE ... | Irving Bryan | SVP, Research | Option Exercise | A | 18.69 | 35,000 | 654,150 | 35,000 | |
| Feb 28 2018 | FPRX | FIVE PRIME THERAPE ... | Irving Bryan | SVP, Research | Grant | A | 0.00 | 6,000 | 0 | 21,000 | 15 K to 21 K (+40.00 %) |
| Sep 05 2017 | FPRX | FIVE PRIME THERAPE ... | Irving Bryan | SVP, Research | Option Exercise | A | 0.00 | 80,000 | 0 | 80,000 | |
| Sep 05 2017 | FPRX | FIVE PRIME THERAPE ... | Irving Bryan | SVP, Research | Grant | A | 0.00 | 15,000 | 0 | 15,000 | 0 to 15 K |
Page: 1